Advertisement

Surgery Today

, 41:1442 | Cite as

Hepatocellular adenoma containing hepatocellular carcinoma in a male patient with familial adenomatous polyposis coli: Report of a case

  • Yuji Toiyama
  • Yasuhiro Inoue
  • Hiromi Yasuda
  • Shigeyuki Yoshiyama
  • Toshimitsu Araki
  • Chikao Miki
  • Masato Kusunoki
Case Report

Abstract

Hepatocellular adenoma (HCA) is a benign condition occurring most frequently in young women using oral contraceptives. We herein report the first case of a 28-year-old man with familial adenomatous polyposis (FAP) who experienced hepatocellular carcinoma (HCC) within HCA. A preoperative computed tomography scan of the abdomen disclosed a tumor measuring 5.8 cm in diameter in the left lobe of the liver. A total proctocolectomy with construction of a linear stapled J-pouch, a hand-sewn ileoanal anastomosis and a liver tumor resection were performed. The pathology of the resected specimen confirmed the diagnosis of HCA containing HCC. Five cases of HCA have been reported that developed in patients with FAP, but this is the first case of HCA containing HCC. Hepatocellular adenomas occur due to the inactivation of hepatic nuclear factor 1α, but the mechanism underlying the malignant transformation from HCA to HCC could not be identified in this case.

Key words

Familial adenomatous polyposis Hepatocellular carcinoma Hepatocellular adenoma β-Catenin Hepatic nuclear factor 1α 

References

  1. 1.
    Edmondson HA, Henderson B, Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 1976;294: 470–472.PubMedCrossRefGoogle Scholar
  2. 2.
    Bluteau O, Jeannot E, Bioulac-Sage P, Marqués JM, Blanc JF, Bui H, et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet 2002;32:312–315.PubMedCrossRefGoogle Scholar
  3. 3.
    Chen YW, Jeng YM, Yeh SH, Chen PJ. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. Hepatology 2002;36: 927–935.PubMedGoogle Scholar
  4. 4.
    Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006;43:515–524.PubMedCrossRefGoogle Scholar
  5. 5.
    Hasegawa K, Kokudo N. Surgical treatment of hepatocellular carcinoma. Surg Today 2009;39:833–843.PubMedCrossRefGoogle Scholar
  6. 6.
    Laurent-Puig P, Zucman-Rossi J. Genetics of hepatocellular tumors. Oncogene 2006;25:3778–3786.PubMedCrossRefGoogle Scholar
  7. 7.
    de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 1998;95:8847–8851.CrossRefGoogle Scholar
  8. 8.
    Bala S, Wunsch PH, Ballhausen WG. Childhood hepatocellular adenoma in familial adenomatous polyposis: mutations in adenomatous polyposis coli gene and p53. Gastroenterology 1997;112: 919–922.PubMedCrossRefGoogle Scholar
  9. 9.
    Bläker H, Sutter C, Kadmon M, Otto HF, Von Knebel-Doeberitz M, Gebert J, et al. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli. Genes Chromosomes Cancer 2004;41:93–98.PubMedCrossRefGoogle Scholar
  10. 10.
    Su LK, Abdalla EK, Law CH, Kohlmann W, Rashid A, Vauthey JN. Biallelic inactivation of the APC gene is associated with hepatocellular carcinoma in familial adenomatous polyposis coli. Cancer 2001;92:332–339.PubMedCrossRefGoogle Scholar
  11. 11.
    Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007;46:740–748.PubMedCrossRefGoogle Scholar
  12. 12.
    Jeannot E, Wendum D, Paye F, Mourra N, de Toma C, Fléjou JF, et al. Hepatocellular adenoma displaying a HNF1α inactivation in a patient with familial adenomatous polyposis coli. J Hepatol 2006;45:883–886.PubMedCrossRefGoogle Scholar
  13. 13.
    Nakao A, Sakagami K, Nakata Y, Komazawa K, Amimoto T, Nakashima K, et al. Multiple hepatic adenomas caused by longterm administration of androgenic steroids for aplastic anemia in association with familial adenomatous polyposis. J Gastroenterol 2000;35:557–562.PubMedCrossRefGoogle Scholar
  14. 14.
    Chen YW, Jeng YM, Yeh SH, Chen PJ. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. Hepatology 2002;36:927–935.PubMedGoogle Scholar
  15. 15.
    Takayasu H, Motoi T, Kanamori Y, Kitano Y, Nakanishi H, Tange T, et al. Two case reports of childhood liver cell adenomas harboring beta-catenin abnormalities. Hum Pathol 2002;33:852–855.PubMedCrossRefGoogle Scholar
  16. 16.
    Torbenson M, Lee JH, Choti M, Gage W, Abraham SC, Montgomery E, et al. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway. Mod Pathol 2002;15: 189–196.PubMedCrossRefGoogle Scholar
  17. 17.
    Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, Imaoka S, et al. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 1998;58:2524–2527.PubMedGoogle Scholar
  18. 18.
    Nhieu JT, Renard CA, Wei Y, Cherqui D, Zafrani ES, Buendia MA. Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation Am J Pathol 1999;155:703–710.PubMedCrossRefGoogle Scholar
  19. 19.
    Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 2001;120:1763–1773.PubMedCrossRefGoogle Scholar
  20. 20.
    Foster JH, Donohue TA, Berman MM. Familial liver-cell adenomas and diabetes mellitus. N Engl J Med 1978;299:239–241.PubMedCrossRefGoogle Scholar
  21. 21.
    Okamura Y, Maeda A, Matsunaga K, Kanemoto H, Furukawa H, Sasaki K, et al. Hepatocellular adenoma in a male with familial adenomatous polyposis coli. J Hepatobiliary Pancreat Surg 2009; 16:571–574.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2011

Authors and Affiliations

  • Yuji Toiyama
    • 1
  • Yasuhiro Inoue
    • 1
  • Hiromi Yasuda
    • 1
  • Shigeyuki Yoshiyama
    • 1
  • Toshimitsu Araki
    • 1
  • Chikao Miki
    • 1
  • Masato Kusunoki
    • 1
  1. 1.Department of Gastrointestinal and Pediatric SurgeryMie University Graduate School of MedicineMieJapan

Personalised recommendations